Literature DB >> 8407753

Side effects of methylphenidate and desipramine alone and in combination in children.

C S Pataki1, G A Carlson, K L Kelly, M D Rapport, T M Biancaniello.   

Abstract

OBJECTIVE: To investigate side effects of methylphenidate and desipramine alone and in combination in hospitalized children with symptoms of attention-deficit hyperactivity disorder and depression.
METHOD: A double-blind placebo controlled crossover design was used to investigate each medication alone and in combination. Side effect ratings and EKGs were done weekly. Pulse and blood pressure were monitored daily.
RESULTS: Nausea, dry mouth, and tremor were present in at least twice as many children on combined methylphenidate and desipramine compared with any other condition. Nausea/vomiting, headaches, other aches, refusal of food, and feeling "tired" were significantly more frequent during the combined methylphenidate plus desipramine condition when compared with either methylphenidate alone or with baseline. Significantly higher ventricular heart rate was found on combined methylphenidate plus desipramine compared with desipramine alone, methylphenidate alone, and baseline. Prolonged PR interval and significantly higher heart rate occurred during desipramine alone compared with baseline.
CONCLUSIONS: During the several-month duration of the study, there were more frequent side effects during combined methylphenidate plus desipramine treatment than with either medication alone. Clinically, side effects present during combined medication appeared to be similar to and no more serious than those associated with desipramine alone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407753     DOI: 10.1097/00004583-199309000-00028

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  17 in total

Review 1.  Safety issues in the use of methylphenidate. An American perspective.

Authors:  M D Rappley
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

Review 2.  Clinically Significant Drug-Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder.

Authors:  Georgios Schoretsanitis; Jose de Leon; Chin B Eap; John M Kane; Michael Paulzen
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

3.  Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.

Authors:  Joshua A Samuels; Kathy Franco; Fiona Wan; Jonathan M Sorof
Journal:  Pediatr Nephrol       Date:  2005-10-28       Impact factor: 3.714

4.  Major Depression with ADHD: In Children and Adolescents.

Authors:  Atilla Turgay; Rubaba Ansari
Journal:  Psychiatry (Edgmont)       Date:  2006-04

5.  Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial.

Authors:  Rozita Davari-Ashtiani; Mahin Eslami Shahrbabaki; Katayoon Razjouyan; Homayoun Amini; Homa Mazhabdar
Journal:  Child Psychiatry Hum Dev       Date:  2010-12

Review 6.  Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.

Authors:  J S Markowitz; K S Patrick
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

7.  Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.

Authors:  Fariba Arabgol; Leily Panaghi; Paria Hebrani
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-06-18       Impact factor: 4.785

8.  An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness.

Authors:  Timothy E Wilens; Paul Hammerness; Linsey Utzinger; Mary Schillinger; Anna Georgiopoulous; Robert L Doyle; Marykate Martelon; Kerry Brodziak
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576

9.  Salivary bacteria and oral health status in medicated and non-medicated children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ariela Hidas; Noam Birman; Avia Fux Noy; Joseph Shapira; Israel Matot; Doron Steinberg; Moti Moskovitz
Journal:  Clin Oral Investig       Date:  2012-11-08       Impact factor: 3.573

Review 10.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.